Plain-English translation of NCT07419724 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is building a specialized research database — called a biobank — that collects blood samples, tissue samples, and medical imaging from patients with portal hypertension, a condition where blood pressure builds up in the liver and causes dangerous bleeding in the esophagus and stomach. The researchers will study these samples using advanced genetic and imaging tools to understand why different patients respond differently to treatment and to develop smarter ways to predict outcomes and guide care decisions.
Right now, doctors don't fully understand why some patients with portal hypertension do better or worse than others, and treatment choices are often based on general guidelines rather than what's best for each individual. By collecting and analyzing biological samples and medical data from a large group of patients, researchers hope to discover patterns that will help doctors personalize treatment and predict complications before they happen.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate blood and possibly tissue samples, and researchers will collect information from your medical records and imaging scans. The study will follow two groups separately — patients whose portal hypertension is caused by liver cirrhosis and patients whose portal hypertension has other causes — to compare how the disease differs between them. Your samples and data will be stored in a research database and used for genetic, imaging, and other advanced analyses over time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China